21
Feb
22
Feb

Dublin

Presented by

IPHA IPHA
BPCI BPCI
NIBRT NIBRT

Event Sponsors

PWC PWC

Agency partners

Intertrade Ireland Intertrade Ireland

Day 1 Plenary session

12.30
Registration
13.00
Opening address
Session 1: Ambition for medical and biopharma innovation
- David L. Chesney, Principal and General Manager, DL Chesney Consulting, LLC
Adapting “current” GMP to innovative technologies – A challenge for regulators

- Dr Lorraine Nolan, Chief Executive, Health Products and Regulatory Authority (HPRA)
European regulations for the 21st Century – the path forward

Followed by panel discussion
14.45
Networking break
15.15
Session 2: The future for genomics and advanced therapeutics
- Kári Stefánsson, M.D., Dr. Med., Founder and CEO, deCODE Genetics
The genetics of common diseases

- Steve Elmore, Vice President, Early Discovery Research, AbbVie

- Louise Jopling, Senior Director Immunology Science, Johnson & Johnson Innovation and
- Prof Colin Hill, Professor of Microbiology, University College Cork
How bacterial viruses can change medicine as we know it

- John Murphy, Vice President, Biology, Rare Disease Research Unit, Pfizer
Gene Therapy at Pfizer: Where we are, where we are going and what we are learning along the way

Followed by panel discussion
17.15
Oliver O’Connor, CEO, Irish Pharmaceutical Healthcare Association (IPHA)
Closing address


Close